Simranjeet Kaur* Salesh Verma, Kanchan

Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, Ludhiana, Punjab, India

*Corresponding Author: Simranjeet Kaur, Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, Ludhiana, Punjab, India.

Received: January 22, 2024; Published: February 29, 2024

Abstract

Juvenile idiopathic arthritis (JIA) is a heterogeneous group of idiopathic inflammatory arthritis affecting children younger than 16 years of age and lasting six weeks or longer. Depending on the number of joints affected, presence of extra-articular manifestations, systemic symptoms, serology and genetic factors, JIA is divided into oligoarticular, polyarticular, systemic, psoriatic, enthesitis-related and undifferentiated arthritis. The illness can run in families but can also be caused by particular factors. Treatment of JIA requires anti-inflammatory and immunomodulatory drugs and physical therapy, and eventually, surgery, nutritional support, and psychosocial support may be needed. Patients 4 to 17 years of age with polyarticular-course juvenile rheumatoid arthritis who had active disease (at least five swollen joints and at least three joints with limitation of motion) that had not responded adequately to treatment with nonsteroidal antiinflammatory drugs (NSAIDs) are taken for the study.

 Keywords: Juvenile Idiopathic Arthritis (JIA); Illness

References

1. Thatayatikom A., et al. “Juvenile Idiopathic Arthritis”. StatPearls Publishing (2023).
2. OrthoInfo- Juvenile Arthritis (2022).
3. World Arthritis Day 2022: Doctor debunks myths about arthritis in India, Delhi, Oct 12, (2022).
4. Cronstein BN and Aune TM. “Methotrexate and its mechanisms of action in inflammatory arthritis”. Nature Reviews Rheumatology 16 (2020): 145-154.
5. Maryam Hanoodi and Meenal Mittal. “Vassar Brothers Medical Center-Methotrexate” (2023).
6. Mulligan K., et al. “Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life”. Pediatric Rheumatology 11 (2013): 23.
7. Sophia Entringer, PharmD. – Methotrexate (2023).
8. Carter R Ellis; Chaudhary Ehtsham Azmat, Medical University of South Carolina1, Rawalpindi Medical College and Allied Hospitals (2023).
9. Samah I Nasef, MD, MRCP (Rheumatology) Department of Physical Medicine, Rheumatology, and Rehabilitation, Faculty of Medicine, Suez Canal University, Ismailia, Egypt- Juvenile Idiopathic Arthritis 24.2 (2021): 93-103.
10. Zaripova LN., et al. “Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches”. Pediatric Rheumatology 19 (2021):

Citation

Citation: Simranjeet Kaur., et al. “A Case of Localized Amyloid Angiopathy Following Aneurysmal Subarachnoid Hemorrhage - Strong Evidence of Dysfunction of the Glymphatic System”. Acta Scientific Neurology 7.3 (2024): 55-61.

Copyright

Copyright: © 2024 Simranjeet Kaur., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.